Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 3 583 548 | déclaré | 05 mars 2026 | tx 44+3 281 830−1 033 959 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 05 mars 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 248 865 | 0.00 USD | |
| 05 mars 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 373 295 | 0.00 USD | deriv |
| 02 mars 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 29 282 | 14.48 USD | |
| 02 févr. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 15 500 | 14.68 USD | |
| 16 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2 818 | 7.57 USD | |
| 16 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 1 974 | 13.83 USD | |
| 15 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197 182 | 7.57 USD | |
| 15 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 136 193 | 13.59 USD | |
| 15 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197 182 | 0.00 USD | deriv |
| 16 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2 818 | 0.00 USD | deriv |
| 06 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 7 715 | 11.09 USD | |
| 30 sept. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 29 733 | 14.34 USD | |
| 30 sept. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 200 | 15.00 USD | |
| 31 mars 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 21 490 | 3.47 USD | |
| 06 mars 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 180 118 | 0.00 USD | |
| 06 mars 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 270 177 | 0.00 USD | deriv |
| 03 mars 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 4 595 | 3.17 USD | |
| 03 févr. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 11 851 | 3.47 USD | |
| 06 janv. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 7 471 | 4.05 USD | |
| 30 sept. 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 18 589 | 3.20 USD | |
| 23 sept. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 1 857 | 1.57 USD | |
| 23 sept. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 1 857 | 0.00 USD | deriv |
| 12 sept. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 34 449 | 1.57 USD | |
| 12 sept. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 34 449 | 0.00 USD | deriv |
| 16 avr. 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 179 850 | 0.00 USD |